Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Subst Abuse Treat. 2013 Aug 27;46(2):10.1016/j.jsat.2013.07.009. doi: 10.1016/j.jsat.2013.07.009

Table 2.

Smoking characteristics as a function of treatment modality

% (N)/Mean (SD) p value
ORT Non-ORT
FTND (81) (91) 0.002

  Mean (SD) 5.1 (2.0) 4.2 (2.0)

Cigarettes/day (96) (106) 0.05

  Mean (SD) 12.9 (7.4) 10.6 (5.7)

Use of other tobacco products ever? (96) (101) 0.1

  Cigars 15 14
  Smokeless tobacco 5 2
  E-cigarettes 26 14
  SNUS 1 1

Menthol cigarettes (58) (64) 0.04

  Mentholated 81 92
  Non-mentholated 19 8

Age of regular smoking (96) (103) 0.3

  Mean (SD) 15.8 (5) 16.6 (6)

Days/week of smoking before treatment (97) (106) 0.5

  Mean (SD) 6.4 (1.5) 6.3 (1.5)

Cigarettes/day before treatment (93) (102) 0.04

  Mean (SD) 14.2 (9.6) 11.0 (5.9)

Smoking changes since entering treatment (95) (102) 0.2

  Smoke more 31 19
  Smoke less 24 32
  Smoke the same 45 49

Note: Significant treatment group differences determined via linear and generalized linear mixed models with clinic site defined as a random effect.

HHS Vulnerability Disclosure